GLPwatch

Fluorescent exendin-4 derivatives for pancreatic β-cell analysis.

Bioconjug Chem · 2014

Last updated 2026-05-28

Researchers modified a GLP-1 drug called exendin-4 to create fluorescent versions that can bind to insulin-producing pancreatic beta cells. They tested over 25 compounds and found several that effectively attach to these cells, allowing them to be studied using lab techniques like flow cytometry and microscopy.

AI summary of the abstract below.

JournalBioconjug Chem, 2014
Citations35
Relative citation ratio1.08
NIH percentile53
Molecules
Conditions studied Type 2 Diabetes

Abstract

The ability to reliably identify pancreatic β-cells would have far reaching implications for a greater understanding of β-cell biology, measurement of β-cell mass in diabetes, islet transplantation, and drug development. The glucagon-like peptide-1 receptor (GLP1R) is highly expressed on the surface of insulin producing pancreatic β-cells. Using systematic modifications of the GLP1R ligand, exendin-4, we screened over 25 compounds and identified a palette of fluorescent exendin-4 with high GLP1R binding affinity. We show considerable differences in affinity, as well as utility of the top candidates for flow cytometry and microscopy of β-cells. Some of the developed compounds should be particularly useful for basic and translational β-cell research.

Verbatim abstract via PubMed 24328216 ↗